BIO-key International (NASDAQ:BKYI – Get Free Report) announced its earnings results on Wednesday. The technology company reported ($1.00) EPS for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.46), Zacks reports. The firm had revenue of $1.14 million during the quarter. BIO-key International had a negative return on equity of 340.45% and a negative net margin of 96.03%.
BIO-key International Price Performance
NASDAQ:BKYI traded down $0.15 during trading hours on Thursday, hitting $1.25. 30,529 shares of the company were exchanged, compared to its average volume of 70,046. The company has a quick ratio of 0.55, a current ratio of 0.68 and a debt-to-equity ratio of 0.28. BIO-key International has a 52-week low of $1.23 and a 52-week high of $12.42. The company’s 50 day moving average price is $1.59 and its 200-day moving average price is $1.77.
BIO-key International Company Profile
Featured Stories
- Five stocks we like better than BIO-key International
- 3 Fintech Stocks With Good 2021 Prospects
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Jeff Brown’s Exegesis AI Stock Picks
- The Role Economic Reports Play in a Successful Investment Strategy
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.